• Human Tyrosine-protein kinase receptor UFO/Axl protein (Recombinant) (C-His) (STJP000863)
  • Human Tyrosine-protein kinase receptor UFO/Axl protein (Recombinant) (C-His) (STJP000863)
  • Human Tyrosine-protein kinase receptor UFO/Axl protein (Recombinant) (C-His) (STJP000863)
  • Human Tyrosine-protein kinase receptor UFO/Axl protein (Recombinant) (C-His) (STJP000863)

Human Tyrosine-protein kinase receptor UFO/Axl protein (Recombinant) (C-His) (STJP000863)

SKU:
STJP000863

Current Stock:
Host: HEK293 cells
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human Tyrosine-protein kinase receptor UFO/Axl-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications.
Formulation: Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. Contact us for customized product form or formulation.
Immunoreactivity: Measured by its binding ability in a functional ELISA. Immobilized Human AXL at 2 Mu g/mL (100 Mu L/well) can bind Human Gas6 with a linear range of 1.22-5.49 ng/mL.
Gene Symbol: AXL
Gene ID: 558
Uniprot ID: UFO_HUMAN
Immunogen: Recombinant Human Tyrosine-protein kinase receptor UFO/Axl Protein is produced by HEK293 expression system. The target protein is expressed with sequence (Glu33-Pro449) of human Axl (Accession #NP_001690.2) fused with a 6Ă—His tag at the C-terminus.
Tissue Specificity Highly expressed in metastatic colon tumors. Expressed in primary colon tumors. Weakly expressed in normal colon tissue.
Post Translational Modifications Monoubiquitinated upon GAS6-binding. A very small proportion of the receptor could be subjected to polyubiquitination in a very transient fashion. Phosphorylated at tyrosine residues by autocatalysis, which activates kinase activity.
Function Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding growth factor GAS6 and which is thus regulating many physiological processes including cell survival, cell proliferation, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of AXL. Following activation by ligand, AXL binds and induces tyrosine phosphorylation of PI3-kinase subunits PIK3R1, PIK3R2 and PIK3R3.but also GRB2, PLCG1, LCK and PTPN11. Other downstream substrate candidates for AXL are CBL, NCK2, SOCS1 and TNS2. Recruitment of GRB2 and phosphatidylinositol 3 kinase regulatory subunits by AXL leads to the downstream activation of the AKT kinase. GAS6/AXL signaling plays a role in various processes such as endothelial cell survival during acidification by preventing apoptosis, optimal cytokine signaling during human natural killer cell development, hepatic regeneration, gonadotropin-releasing hormone neuron survival and migration, platelet activation, or regulation of thrombotic responses. Also plays an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response. (Microbial infection) Acts as a receptor for lassa virus and lymphocytic choriomeningitis virus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope. (Microbial infection) Acts as a receptor for Ebolavirus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope. (Microbial infection) Promotes Zika virus entry in glial cells, Sertoli cells and astrocytes. Additionally, Zika virus potentiates AXL kinase activity to antagonize type I interferon signaling and thereby promotes infection. Interferon signaling inhibition occurs via an SOCS1-dependent mechanism.
Protein Name Tyrosine-Protein Kinase Receptor Ufo
Axl Oncogene
Database Links Reactome: R-HSA-4420097
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Alternative Protein Names Tyrosine-Protein Kinase Receptor Ufo protein
Axl Oncogene protein
AXL protein
UFO protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance